Contraception. 1982 Mar;25(3):231-41. doi: 10.1016/0010-7824(82)90046-4.
A randomized controlled clinical trial comparing six combined oral contraceptives with 50 micrograms or less of ethinyl estradiol was undertaken in 10 WHO Collaborating Centres for Clinical Research in Human Reproduction. A total of 2430 women entered the trial and were observed for 28,077 woman-cycles. All low-dose combined oral contraceptives demonstrated equivalent efficiency with one-year pregnancy rates of one to six percent. However, discontinuation rates for medical reasons differed significantly between the treatment groups, with the preparation containing 20 micrograms ethinyl estradiol and that containing 400 micrograms norethisterone acetate being associated with higher discontinuation rates due to bleeding disturbances. Even among the preparations which did not differ in discontinuation rates, the reasons for discontinuation did differ. Women receiving norethisterone preparations tended to discontinue because of bleeding disturbances while those receiving the levonorgestrel-containing preparations tended to discontinue because of complaints of nausea and vomiting.
世界卫生组织10个人类生殖临床研究合作中心开展了一项随机对照临床试验,比较了6种炔雌醇含量为50微克及以下的复方口服避孕药。共有2430名女性参与试验,观察周期达28077个妇女周期。所有低剂量复方口服避孕药的避孕效果相当,一年妊娠率为1%至6%。然而,各治疗组因医学原因的停药率存在显著差异,含20微克炔雌醇和400微克醋酸炔诺酮的制剂因出血紊乱导致的停药率较高。即使在停药率无差异的制剂中,停药原因也有所不同。服用炔诺酮制剂的女性往往因出血紊乱而停药,而服用含左炔诺孕酮制剂的女性则往往因恶心和呕吐症状而停药。